MSBIP
Midland States Bancorp, Inc.
$25.44
+0.18%
$527.4M
No data for this timeframe.
Vol
Market Cap$527.4M
Cap SizeSmall Cap
SEC Reports3
Recent Activity
May 11, 2026
SEC
Midland States Bancorp appointed Claire A. Stack as permanent CFO, effective May 8, 2026, after she served as interim CF
8-K — Impact 2/10
May 5, 2026
SEC
Midland States Bancorp increased its stock repurchase authorization from $25M to $45M and extended the program to Decemb
8-K — Impact 3/10
Apr 23, 2026
SEC
Midland States Bancorp reported a strong rebound in Q1 2026 with $0.74 diluted EPS, reversing a prior quarter loss, driv
8-K — Impact 8/10
Analyst Ratings
0Strong Buy
0Buy
7Hold
1Sell
2Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
Midland States Bancorp appointed Claire A. Stack as permanent CFO, effective May 8, 2026, after she served as interim CF
May 11, 2026
NEUTRAL
8-K
3/10
Midland States Bancorp increased its stock repurchase authorization from $25M to $45M and extended the program to Decemb
May 5, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.3/10.
NEUTRAL
8-K
2/10
Midland States Bancorp appointed Claire A. Stack as permanent CFO, effective May 8, 2026, after she
May 11, 2026
NEUTRAL
8-K
3/10
Midland States Bancorp increased its stock repurchase authorization from $25M to $45M and extended t
May 5, 2026
BULLISH
8-K
8/10
Midland States Bancorp reported a strong rebound in Q1 2026 with $0.74 diluted EPS, reversing a prio
Apr 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 10 analysts — 0 strong buy, 0 buy, 7 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 7 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.